@inproceedings{29625a00a6744450aed74ddad8f218cc,
title = "Clinical Trials on Alternative Medicines for COVID-19",
abstract = "In this study, we addressed the alternative medications that have been targeted in the clinical trials (CTs) to be evidenced as an adjuvant treatment against COVID-19. Based on the outcomes from CTs, we found that dietary supplements such as Lactoferrin, and Probiotics (as SivoMixx) can play a role enhancing the immunity thus can be used as prophylactics against COVID-19 infection. Vitamin D was proven as an effective adjuvant treatment against COVID-19, while Vitamin C role is uncertain and needs more investigation. Herbals such as Guduchi Ghan Vati can be used as prophylactic, while Resveratrol can be used to reduce the hospitalization risk of COVID-19 patients. On the contrary, there were no clinical improvements demonstrated when using Cannabidiol. This study is a part of a two-phase research study. In the first phase, we gathered evidence-based information on alternative therapeutics for COVID-19 that are under CT. In the second phase, we plan to build a mobile health application that will provide evidence based alternative therapy information to health consumers.",
keywords = "Alternative medicine, COVID-19, Clinical trial, Coronavirus",
author = "Jaber, {Bassam Ali} and Rizwan Qureshi and Alaa Abd-Alrazaq and Rahman, {Mohammad Azizur} and Mowafa Househ and Zubair Shah and Tanvir Alam",
note = "Publisher Copyright: {\textcopyright} 2022 The authors and IOS Press.",
year = "2022",
doi = "10.3233/SHTI220740",
language = "English",
series = "Studies in Health Technology and Informatics",
publisher = "IOS Press BV",
pages = "366--369",
editor = "John Mantas and Parisis Gallos and Emmanouil Zoulias and Arie Hasman and Househ, {Mowafa S.} and Marianna Diomidous and Joseph Liaskos and Martha Charalampidou",
booktitle = "Advances in Informatics, Management and Technology in Healthcare",
address = "Netherlands",
}